Letter to the editor: Is it time to change the standard TIPS procedure?
Xuefeng Luo, Li Yang – 12 June 2022
Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation
Xiaowen Ma, Allen Chen, Luma Melo, Ana Clemente‐Sanchez, Xiaojuan Chao, Ali Reza Ahmadi, Brandon Peiffer, Zhaoli Sun, Hiromi Sesaki, Tiangang Li, Xiaokun Wang, Wanqing Liu, Ramon Bataller, Hong‐Min Ni, Wen‐Xing Ding – 12 June 2022
Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2−/− mouse model of sclerosing cholangitis via immunomodulatory effects
Claudia D. Fuchs, Emmanuel D. Dixon, Tim Hendrikx, Veronika Mlitz, Annika Wahlström, Marcus Ståhlman, Hubert Scharnagl, Tatjana Stojakovic, Christoph J. Binder, Hanns‐Ulrich Marschall, Michael Trauner – 11 June 2022 – Bile salt export pump (Bsep) (Abcb11)−/− mice are protected from acquired cholestatic injury due to metabolic preconditioning with a hydrophilic bile acid (BA) pool with formation of tetrahydroxylated bile acids (THBAs).
A single hepatitis B virus genome with a reporter allows the entire viral life cycle to be monitored in primary human hepatocytes
Ariunaa Sumiyadorj, Kazuhisa Murai, Tetsuro Shimakami, Kazuyuki Kuroki, Tomoki Nishikawa, Masaki Kakuya, Atsumu Yamada, Ying Wang, Atsuya Ishida, Takayoshi Shirasaki, Shotaro Kawase, Ying‐Yi Li, Hikari Okada, Kouki Nio, Kazunori Kawaguchi, Taro Yamashita, Yoshio Sakai, Davaadorj Duger, Eishiro Mizukoshi, Masao Honda, Shuichi Kaneko – 11 June 2022 – For the development of antiviral agents to eliminate hepatitis B virus (HBV), it is essential to establish an HBV cell culture system that can easily monitor HBV infection.
Macrophage‐derived MLKL in alcohol‐associated liver disease: Regulation of phagocytosis
Xiaoqin Wu, Xiude Fan, Megan R. McMullen, Tatsunori Miyata, Adam Kim, Vai Pathak, Jianguo Wu, Le Z. Day, Josiah E. Hardesty, Nicole Welch, Jaividhya Dasarathy, Daniela S. Allende, Arthur J. McCullough, Jon M. Jacobs, Daniel M. Rotroff, Srinivasan Dasarathy, Laura E. Nagy – 10 June 2022
Letter to the editor: Is NAFLD a bystander or contributor to coronary artery disease?
Ziyu Xun, Haitao Zhao – 10 June 2022
Reply
Douglas N. VanDerwerken, Nick L. Wood, Dorry L. Segev, Sommer E. Gentry – 10 June 2022
Reply
Zhewen Ren, Pomme I. H. G. Simons, Anke Wesselius, Coen D. A. Stehouwer, Martijn C. G. J. Brouwers – 10 June 2022
Probiotic‐derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation
Mengwei Jiang, Fengyuan Li, Yunhuan Liu, Zelin Gu, Lihua Zhang, Jiyeon Lee, Liqing He, Vatsalya Vatsalya, Huang‐Ge Zhang, Zhongbin Deng, Xiang Zhang, Shao‐Yu Chen, Grace L. Guo, Shirish Barve, Craig J. McClain, Wenke Feng – 10 June 2022